Leslie Tietjen
Nurse Practitioner · Medford, ORNPI 1164071858
Payments from drug & device makers
Across 34 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$209
- Lilly USA, LLC$68
- Takeda Pharmaceuticals U.S.A., Inc.$42
- Edwards Lifesciences$40
- Daiichi Sankyo Inc.$30
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$25
- plus $87 from 5 others
What the payments were for
- Food & beverage$500100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $209 |
| Lilly USA, LLC | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Edwards Lifesciences | 1 | $40 |
| Daiichi Sankyo Inc. | 2 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| Solventum Corporation | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
How this compares
$500 in reported general payments places this provider in the 90th percentile of 997 nurse practitioner providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 169 | $195,485 |
| EntrestoSacubitril/Valsartan | 69 | $78,466 |
| XareltoRivaroxaban | 60 | $63,512 |
| JardianceEmpagliflozin | 30 | $28,466 |
| BrilintaTicagrelor | 16 | $18,627 |
| Repatha SureclickEvolocumab | 18 | $18,216 |
| FarxigaDapagliflozin Propanediol | 14 | $11,735 |
| Metoprolol Succinate | 266 | $4,732 |
| Ranolazine ErRanolazine | 23 | $4,562 |
| Rosuvastatin Calcium | 137 | $3,415 |
| Potassium Chloride | 101 | $2,728 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 73 | $2,386 |
| Flecainide Acetate | 41 | $2,069 |
| Atorvastatin Calcium | 83 | $1,527 |
| Losartan Potassium | 127 | $1,298 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Medford
- Maria RiveraMedford$2K
- Johnny PayneMedford$2K
- Jared ThomasMedford$2K
- Cynthia MosserMedford$2K
- Nicolette CortezMedford$1K
- Heather MataMedford$862
- Whitney CoultasMedford$848
- Alicia DuyvejonckSpringfield$299K
- Summer HarnessLake Oswego$113K
- Alana WilsonPortland$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.